Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Trading Update

5 Jan 2011 07:00

RNS Number : 8727Y
Biofutures International plc
05 January 2011
 

Biofutures International plc

 

("Biofutures" or "the Company")

 

Refinery Commissioning Completed

 

 

Biofutures is pleased to confirm that all equipment and automatic control systems in the Zurex refinery have been successfully commissioned.

 

The Company intends to commence operations as a third-party contract refiner, capitalising on the expressions of interest from a number of mill owners who currently have insufficient or no refining capabilities.

 

The next step will be for the Company to progress to refining its own palm oil. The intention is to do this under agreed customer arrangements.

 

For further information, please contact:

 

Biofutures International plc

Tel: + 6012 315 0626

Joe Wong, Chief Executive Officer

www.biofuturesplc.com

 

Daniel Stewart & Company plc

Tel: + 44 (0) 20 7776 6550

Oliver Rigby/Antony Legge (Nomad)

Colin Rowbury (Broker)

www.danielstewart.co.uk

 

 

The construction update and photographs are also available on the Company's web site at http://www.biofuturesplc.com/construction_update

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSFFELFFSELF
Date   Source Headline
7th Apr 20147:00 amRNSJoint Venture with Scomi
7th Apr 20147:00 amRNSHeads of Agreement with Emery Advanced Materials
6th Feb 20147:00 amRNSCommissioning Update
19th Dec 20137:00 amRNSProgress on Graphene Development
18th Dec 20137:00 amRNSUpdate on Senawang Facility
3rd Dec 20137:00 amRNSSenior Management Appointment
26th Nov 20137:00 amRNSTrading Update and Collaboration with Scomi
31st Oct 20139:21 amRNSTrading Update
21st Oct 20137:00 amRNSLahad Datu Refinery Resumes Operations
15th Oct 20137:00 amRNSUpgrade of Senawang Facility and Plant Shutdown
7th Oct 20138:23 amRNSContract renewal with Shell Malaysia
30th Sep 20137:00 amRNSInterim results
17th Sep 20137:00 amRNSPlatClear receives EPA Approval
5th Aug 20137:00 amRNSContract win
1st Aug 20137:00 amRNSContract win
28th Jun 20132:00 pmRNSResult of AGM
3rd Jun 20139:45 amRNSFinal Results
3rd Jun 20137:15 amRNSFinal Results
30th May 201312:29 pmRNSNotice of Results
29th May 20137:00 amRNSNew customer
22nd Apr 20137:00 amRNSContract Volume Doubled
3rd Apr 20137:00 amRNSDirector/PDMR Shareholding
26th Mar 20137:01 amRNSTrading Update
26th Mar 20137:00 amRNSFirst Day of Dealings
25th Mar 201310:44 amRNSResult of General Meeting
15th Mar 201312:59 pmRNSHolding(s) in Company
11th Mar 20139:55 amRNSSchedule 1 - Biofutures International Plc
11th Mar 20137:30 amRNSRestoration - Biofutures International Plc
8th Mar 20136:04 pmRNSAcquisition and Placing
4th Feb 201310:52 amRNSChange of Company Secretary & Registered Office
10th Dec 20121:00 pmRNSSuspension - Biofutures International Plc
10th Dec 20121:00 pmRNSTemporary Suspension
27th Sep 20127:00 amRNSHalf Yearly Report
30th Aug 20124:40 pmRNSSecond Price Monitoring Extn
30th Aug 20124:35 pmRNSPrice Monitoring Extension
26th Jul 20127:00 amRNSResolution of Dispute
15th Jun 201210:23 amRNSReplacement Result of AGM
15th Jun 201210:12 amRNSResult of AGM
28th May 20127:00 amRNSNotice of AGM
23rd Mar 20129:00 amRNSBoard Changes
13th Feb 20129:00 amRNSResult of Arbitration
11th Jan 20128:58 amRNSHolding(s) in Company
27th Oct 20118:33 amRNSPipeline Installation & Connection Contract Update
29th Sep 201111:15 amRNSHalf Yearly Report for 6 months ended 30 June 2011
29th Jun 201111:57 amRNSResult of AGM & Board Changes
25th May 20117:00 amRNSFinal Results
29th Mar 20111:58 pmRNSOperations and Strategy Update
31st Jan 20112:20 pmRNSTR-1 Notification of Major Interest in Shares
10th Jan 20118:51 amRNSBoard Appointment
6th Jan 20117:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.